Magnesium L-Threonate Supplement Manufacturer

Two factories can both print “magnesium L-threonate 2,000 mg” and be quoting different projects. Unusually for a mineral salt, most of what separates them is published rather than proprietary.

The published specification

Because the material was authorised as a novel food in the EU, its composition is set out in the Union list [2]. That gives a buyer something no supplier letter can: a regulator-published window to hold any COA against.

Two of those fields separate a qualified supplier from an unqualified one faster than assay does. Oxalic acid is capped at 1% because it is a synthesis-related residue, and EFSA’s assessment rested on additional oxalic acid exposure staying below roughly 30 mg per day at the maximum intake [4]. Ethanol is a residual solvent from the same route. A COA that reports magnesium and nothing else has not demonstrated that the material meets the authorised composition, and a supplier who has never been asked for oxalic acid usually cannot produce a historical result for it.

Identity is also more specific than the trade name suggests. The authorised substance is the L-isomer as the monohydrate. A specification or COA reading only “magnesium threonate” has not named the isomer or the hydrate state, and neither has been established by the product name.

Branded versus unbranded material, and why that is not only a trademark question

The branded ingredient sits on patents held by Neurocentria, Inc. and is supplied under exclusive licence by ThreoTech, LLC, which states publicly that magnesium L-threonate sold without the brand name is not produced under its patented process and is not authorised. Unbranded material is nevertheless offered by other suppliers, and we manufacture from either one when the brand has qualified it.

What we cannot do is clear it for you. Whether a specific unbranded material, and the use you intend for it, are free of third-party patent and trademark rights in your destination market is a question for the brand owner’s counsel. A contract manufacturer can verify that a drum matches an approved specification; it cannot certify freedom to operate, and any factory that tells you otherwise is selling you a risk it does not carry. Printing the trademark on Supplement Facts is the separate, simpler question: that requires authorisation and the licensor’s specification.

The EU and GB position, which settles the fork for you

For a European launch this stops being a preference. Magnesium L-threonate was authorised as a novel food on 7 November 2024 [2] and added to the list of permitted magnesium sources in Annex II of the food supplements directive, usable in EU food supplement manufacture from 26 November 2025 [3].

The authorisation carries five-year data protection. Until 7 November 2029, magnesium L-threonate may be placed on the EU market only by the applicant, AIDP Inc. — in practice through it and its licensee — unless a later applicant obtains its own authorisation without relying on the protected data, or the applicant agrees [2]. An unbranded drum bought elsewhere does not open an EU route on its own, however good its COA is.

Three conditions travel with the authorisation, and all three land on artwork:

• Use is limited to food supplements for adults, excluding pregnant and lactating women.
• The maximum level is 250 mg of magnesium per day — expressed as magnesium, not as the compound [2].
• The label must designate the ingredient “Magnesium L-threonate”, and the supplement must carry a statement that it should be consumed by adults only, excluding pregnant and lactating women [2].

Great Britain authorised the material separately, with the same 250 mg magnesium per day maximum, but with mandatory wording drafted differently — it addresses persons under 18 rather than adults only [5]. Two markets, two label versions, one material.

Compound weight versus elemental magnesium

The number a consumer reads as “2,000 mg” is compound weight. At the published 7.2%–8.3% magnesium, the elemental line inside a 2,000 mg serving is roughly 145 to 165 mg, and a published US label pattern for the branded ingredient declares 2,000 mg of the ingredient alongside 144 mg of magnesium across three capsules [6].

The regulatory cap and the arithmetic meet at the same point: 250 mg of magnesium is about 3,000 mg of material, which is also the daily intake EFSA assessed [4]. So the EU ceiling is, in practical terms, a three-gram serving — and everything downstream on this page is a consequence of carrying grams rather than milligrams. An elemental figure by itself is not something a factory can produce against, for this salt or any other: what a magnesium specification has to carry beyond it sets out the rest of the fields. Our general approach to supplier documentation is set out in how to read a COA.

Two threonate quotes are comparable when the material identity and hydrate, the branded or unbranded basis, the destination market, the compound weight, the elemental magnesium with its method, and the units per serving line up together. Any one of those missing, and you are comparing numbers rather than products. The general version of this problem, across all magnesium salts, is set out in why two magnesium labels are not comparable.

Send two supplier COAs with the destination market named.

An incoming COA establishes what arrived at the door. It does not establish what a serving of the finished product delivers. How finished-product magnesium is tested covers the release side in more detail than a product page can.

Four stages close it. Raw-material qualification confirms identity and hydrate, magnesium and L-threonate content, oxalic acid and residual ethanol, loss on drying, contaminants, and — where the destination requires it — the authorisation status of the material itself. Formula calculation converts the elemental target to compound weight, compound weight to total fill weight, and fill weight to capsule size and count, tablet weight, or grams per stick. Dosage-form confirmation proves it on trial: fill weight consistency across a split serving, compression and disintegration for tablets, dispersion and taste for a stick. Finished-product release covers the finished specification, batch COA, and finished-unit assay where the market or the retailer requires it.

Results outside the agreed specification go on hold for investigation, and a batch is released only after the deviation is closed under a documented QA procedure. In-house laboratory work is supported by SGS or Eurofins pathways where the RFQ calls for a third-party report; our general approach is set out under quality control.

One limitation is worth stating, because it decides how much the paperwork matters. A finished-unit magnesium assay measures elemental magnesium; it does not identify which magnesium source delivered it, and it cannot distinguish branded from unbranded material. On a dual-salt architecture it cannot separate the two contributions either. The material basis is therefore established in writing at qualification, not inferred from a release result afterwards.

To get a quote that survives contact with production, send the destination market, the closest architecture or the full BOM, whether the panel will print the trademark and whether authorisation is in hand, the compound weight per serving and per unit, the elemental magnesium target with the method you want on the COA, the format and the unit count your customer will accept, shell preference, any companion actives, and the existing COA if a supplier is already selected. Where a field is missing on one side of a comparison, we will tell you which question to put back to that supplier instead of estimating around it.

Serving size is built from the elemental magnesium target, the qualified lot’s assay, the fill capacity of the format, and the destination market’s requirements — in that order. Both the elemental magnesium per serving and the number of units per serving are declared on the panel, and on this salt the unit count is the figure that gets negotiated. Percentage daily value follows the destination label rules and the elemental line, and overage follows stability data for that material and pack rather than a default allowance.

For a European or UK product, the authorised maximum of 250 mg of magnesium per day, the adults-only restriction, and the mandatory on-pack statement are formulation inputs, not late label additions — they constrain the serving before artwork begins [2][5]. For US formulation review, NIH lists a tolerable upper intake level of 350 mg/day for magnesium from dietary supplements and medications for adults, which excludes magnesium naturally present in food [1]. These are regulatory and nutrition references used in safety and label review, not recommended intakes, and milligram figures on this page are development and specification examples.

Positioning stays inside the structure/function framework, with substantiation held by the marketer, FDA notification within 30 days of marketing, and the required disclaimer on the label [7]. Three boundaries carry real artwork risk on this ingredient: research conducted on the branded material does not transfer to an unbranded drum; blood-brain-barrier language is a substantiation question for the brand’s counsel rather than a factory specification; and dementia, Alzheimer’s disease, ADHD, and insomnia treatment language is outside the supplement framework in any market. Gastrointestinal discomfort can occur with oral magnesium, and destination-market warnings, drug-timing statements, and population exclusions are reviewed against the finished formula rather than copied between SKUs.

Packaging is specified for moisture protection first, then for the unit count the serving requires, then for a panel that has to carry two magnesium figures and, in the EU or UK, a mandatory statement. HDPE or PET bottles with induction sealing are a common starting point, with desiccant where the formula and lane call for it, and bottle counts follow the serving: a three-capsule serving and a one-capsule serving do not share a count. Shelf life comes from the formulation, pack, storage conditions, and stability data for that material.

Minimum order quantities depend on the dosage form, the packaging format, the material basis, and how much custom work the formula needs, so they are confirmed against your brief rather than published as a single figure. Sampling follows specification approval, because a sample made from an unqualified material tells you very little about the product you would receive — particularly here, where the material’s authorisation status can decide whether the SKU is sellable at all. Bulk kilogram quantities and finished-unit quantities are quoted separately, and where a branded material is specified, lead time follows authorisation and drum availability rather than our production calendar.

Request a sample and the release specification.

Is the branded ingredient the same thing as magnesium L-threonate?

The branded ingredient is a patented, licensed magnesium L-threonate; magnesium L-threonate is the substance. Unbranded material exists and can be manufactured from, but the two are not commercially interchangeable: printing the trademark requires authorisation and the licensor’s specification, the underlying patents are held and enforced by third parties, and in the EU the authorisation holder controls market entry until November 2029. Which of those applies to you depends on your destination market.

Can we sell an unbranded magnesium L-threonate product in the EU?

Not on the strength of a supplier COA alone, at least until 7 November 2029. The novel food authorisation carries data protection that limits EU market placement to the applicant, unless a later applicant obtains an independent authorisation without relying on the protected data or the applicant agrees [2]. For an EU launch inside that window, the route runs through the authorisation holder and its licensee. We will build the product either way; the market-access position is the brand owner’s to establish with counsel.

Why does a bottle show 2,000 mg but only about 144 mg of magnesium?

The larger figure is compound weight and the smaller one is elemental magnesium. The published composition puts magnesium at 7.2% to 8.3% of the material [2], so a 2,000 mg serving yields roughly 145 to 165 mg, and one published US label declares 2,000 mg of the branded ingredient with 144 mg of magnesium across three capsules [6]. A quote that prices “2,000 mg magnesium” without saying which basis it means is not ready to compare.

Why does this salt need two or three capsules?

Because a useful magnesium line requires gram-scale compound weight. Reaching 250 mg of magnesium takes around 3,000 mg of material, and a standard hard capsule holds a few hundred milligrams of powder blend, so the serving is split across units or moved into a stick. Fewer capsules is achievable, but only by declaring less magnesium.

What should the raw-material COA show?

Identity as the L-isomer monohydrate with the method, magnesium and L-threonate content, oxalic acid, residual ethanol, loss on drying, heavy metals and microbiology to the approved specification, and the material’s authorisation status where the destination requires it. Hold the results against the published composition window rather than against a percentage quoted on a website. A COA reporting only “magnesium L-threonate, conforms” has told you nothing you can formulate against.

Can you manufacture from our existing BOM?

Yes. We review the material identity and basis, the elemental magnesium target against the stated unit count, the destination market’s maximum level and mandatory label wording, companion actives and their assays, dosage-form feasibility, and packaging before quoting. Where the BOM declares a magnesium line the specified material cannot deliver in the specified number of units, or a serving that exceeds the destination’s authorised maximum, we raise it at review rather than at first production.